motpoly xr

Generic: lacosamide

Labeler: aucta pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name motpoly xr
Generic Name lacosamide
Labeler aucta pharmaceuticals, inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

lacosamide 150 mg/1

Manufacturer
Aucta Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 73289-0064
Product ID 73289-0064_3a10a8ff-87ff-a36b-e063-6394a90a473c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA216185
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2023-05-05

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 732890064
Hyphenated Format 73289-0064

Supplemental Identifiers

RxCUI
2637018 2637025 2637027 2637030 2637032 2637035
UNII
563KS2PQY5
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name motpoly xr (source: ndc)
Generic Name lacosamide (source: ndc)
Application Number NDA216185 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0064-2)
source: ndc

Packages (1)

73289-0064-2 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0064-2)

Ingredients (1)

lacosamide (150 mg/1)

Linked Drug Pages (1)

MOTPOLY XR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a10a8ff-87ff-a36b-e063-6394a90a473c", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["2637018", "2637025", "2637027", "2637030", "2637032", "2637035"], "spl_set_id": ["fb8235b4-4cd3-6f22-e053-6294a90a545c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Aucta Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0064-2)", "package_ndc": "73289-0064-2", "marketing_start_date": "20230505"}], "brand_name": "MOTPOLY XR", "product_id": "73289-0064_3a10a8ff-87ff-a36b-e063-6394a90a473c", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "73289-0064", "dea_schedule": "CV", "generic_name": "lacosamide", "labeler_name": "Aucta Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MOTPOLY XR", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "150 mg/1"}], "application_number": "NDA216185", "marketing_category": "NDA", "marketing_start_date": "20230505", "listing_expiration_date": "20261231"}